Questcor to Report First Quarter Financial Results on April 28, 2014
24 Aprile 2014 - 1:00PM
PR Newswire (US)
ANAHEIM, Calif., April 24, 2014 /PRNewswire/ -- Questcor
Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will
release first quarter 2014 financial results on Monday, April 28, 2014 after the close of the
U.S. financial markets. In light of Questcor's pending merger with
Mallinckrodt plc, the Company will not
be hosting a conference call to discuss its financial results.
Further details will be available in a Form 10-Q filing to be filed
with the Securities and Exchange Commission after the earnings
release.
About Questcor
Questcor Pharmaceuticals, Inc. is a biopharmaceutical
company focused on the treatment of patients with serious,
difficult-to-treat autoimmune and inflammatory disorders.
Questcor also provides specialty contract manufacturing services to
the global pharmaceutical industry through its wholly-owned
subsidiary BioVectra Inc. For more information about
Questcor, please visit www.questcor.com
SOURCE Questcor Pharmaceuticals, Inc.
Copyright 2014 PR Newswire
Grafico Azioni (MM) (NASDAQ:QCOR)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni (MM) (NASDAQ:QCOR)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Questcor Pharmaceuticals, Inc. Articoli Notizie